Asymmetric sensorineural hearing loss is a risk factor for late ‐onset hearing loss in pediatric cancer survivors following cisplatin treatment

Pediatric Blood&Cancer, EarlyView.

Source: Pediatric Blood and Cancer - October 18, 2018 Category: Cancer & Oncology Authors: Margaret S. Robertson, Susan S. Hayashi, Miranda L. Camet, Kathryn Trinkaus, Jennifer Henry, Robert J. Hayashi Source Type: research